Search

Your search keyword '"Malley, Mary"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Malley, Mary" Remove constraint Author: "Malley, Mary" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
49 results on '"Malley, Mary"'

Search Results

2. Novel 1,4-homofragmentation via an [alpha]-lactone

3. Technetium(V) oxo complexes of substituted propylene diamine dioxime (PnAO) ligands: water-dependent interconversion between syn and anti isomers

8. Sulfonation with inversion by Mitsunobu reaction: an improvement on the original conditions

9. Regioselective coupling of tetraalkylammonium salts of 6-iodo-2-aminopurine to a cyclobutyl triflate: efficient preparation of homochiral BMS-180,194, a potent antiviral carbocyclic nucleoside

10. Peptidomimetic synthesis: A novel, highly stereoselective route to substituted freidinger lactams

11. Synthesis, characterization, and crystal structures of M(DO3A) (M = Fe, Gd) and Na(M(DOTA)) (M = Fe, Y, Gd)

12. Synthesis, characterization, and crystal structure of the gadolinium(III) chelate of (1R,4R,7R)-alpha,alpha',alpha''-trimethyl-1,4,7, 10-tetraazacyclododecane-1,4,7-triacetic acid (DO3MA)

13. The impact of long-term exercise training on psychological function in olderadults

15. The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults

19. Language assessment of monolingual and multilingual children using non-word and sentence repetition tasks.

20. One-pot synthesis and conformational features of N,N'-distributed ketene animals

21. Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672.

22. Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent

25. Utilization of a nitrogen–sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors

30. Silence as a means of preserving the status quo: The case of ante-natal care in Ireland.

32. Molecular design and structure–Activity relationships leading to the potent, selective, and orally active thrombin active site inhibitor BMS-189664

42. Identification of 1-{2-[4-chloro-1′-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4′-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y1 antagonist as an antiplatelet agent.

43. Cannabinoid CB1 receptor ligand binding and function examined through mutagenesis studies of F200 and S383

44. Project SITUP: An Interdisciplinary Quality Improvement Initiative to Reduce Aspiration Pneumonia.

45. Novel synthesis of the hexahydroimidazo[1,5b]isoquinoline scaffold: application to the synthesis of glucocorticoid receptor modulators.

46. Discovery of (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol- 6(2H)-one, a selective, orally active agonist of the 5-HT(2C) receptor.

47. Discovery of potent, orally-active, and muscle-selective androgen receptor modulators based on an N-aryl-hydroxybicyclohydantoin scaffold.

48. Discovery and development of 5-[(5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non-7-yl-methyl]-3-thiophenecarboxylic acid (BMS-587101)--a small molecule antagonist of leukocyte function associated antigen-1.

49. Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.

Catalog

Books, media, physical & digital resources